Evidence map›Paper›PMID 37982748›Full record

ArticleBioinformatics (Oxford, England)2023

CENTRE: a gradient boosting algorithm for Cell-type-specific ENhancer-Target pREdiction.

Trisevgeni Rapakoulia, Sara Lopez Ruiz De Vargas, Persia Akbari Omgba, Verena Laupert, Igor Ulitsky, Martin Vingron

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Machine and Deep Learning Methods for Predicting 3D Genome Organization.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Trisevgeni RapakouliaMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Sara Lopez Ruiz De VargasMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Persia Akbari OmgbaMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Verena LaupertMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Igor UlitskyMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.ORCID 0000-0003-0555-6561
Martin VingronMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany.ORCID 0000-0003-1064-3571

Funding

German Ministry of Education and Research 01IS18037G
6 · The paper itself

Abstract

motivationIdentifying target promoters of active enhancers is a crucial step for realizing gene regulation and deciphering phenotypes and diseases. Up to now, several computational methods were developed to predict enhancer gene interactions, but they require either many epigenomic and transcriptomic experimental assays to generate cell-type (CT)-specific predictions or a single experiment applied to a large cohort of CTs to extract correlations between activities of regulatory elements. Thus, inferring CT-specific enhancer gene interactions in unstudied or poorly annotated CTs becomes a laborious and costly task.

resultsHere, we aim to infer CT-specific enhancer target interactions, using minimal experimental input. We introduce Cell-specific ENhancer Target pREdiction (CENTRE), a machine learning framework that predicts enhancer target interactions in a CT-specific manner, using only gene expression and ChIP-seq data for three histone modifications for the CT of interest. CENTRE exploits the wealth of available datasets and extracts cell-type agnostic statistics to complement the CT-specific information. CENTRE is thoroughly tested across many datasets and CTs and achieves equivalent or superior performance than existing algorithms that require massive experimental data. AVAILABILITY AND IMPLEMENTATION: CENTRE's open-source code is available at GitHub via https://github.com/slrvv/CENTRE.

Indexed as

AlgorithmsEnhancer Elements, GeneticEpigenomicsGene Expression RegulationHumansPromoter Regions, Genetic

Identifiers

PMID37982748
PMCPMC10666202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.